COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.
Stay current on PCCA news and events, market trends, and all things compounding!
Every month, there are new scientific publications involving PCCA products or services. These publications include journal articles, conference abstracts, conference posters, technical reports and case studies. Maria Carvalho , PharmD, MRPharmS, PhD, is the Manager of PCCA Science, she dives into some of the exciting updates for compounders.
PCCA's own Ranel Larsen of Clinical Services gives the low-down on our HRT Symposium. She has lots to say about how compounders use HRT to help patients around the globe. "It is the compounding industry’s biggest hormone replacement event," she says, "And this year was no exception.."
In recognition of National Autism Awareness Month, Tricia Heitman of PCCA's clinical services team, discusses ways in which compounders help families and patients work to manage the obstacles autism presents.
The experts in our Clinical Services and Formulation Development departments recommend Lipoderm as a first choice for customized transdermal medications. Here’s why.
Daniel Banov talks about water activity in various products and why they are becoming increasingly important in the pharmacy compounding world.
Tadalafil is now free of patents, and compounding pharmacies have some opportunities to use this drug in various customized medications. PCCA's Nat Jones drops in to tell us why that is such exciting news for compounding pharmacies and their patients.
PCCA's own Sebastian Denison to speak on the LDN Radio Show on February 20th, at 3 p.m. CT!
Mike and Seb had a tremendous January, meeting with industry leaders Dr. Pamela Wartian Smith, Saad Dinno, and Bryan Prescott. You can connect to the best pharmacy compounding podcast on the web right here!
Late last year, we were excited to debut PermE8™ Anhydrous Gel, a new compounding base that holds a lot of potential for compounding pharmacies and their patients, especially when it comes to pain management.
We’re excited that patients and physicians now have access to Azelastine Hydrochloride USP as an ingredient option in compounded medications. There are some commercial products available, including a combination product, but when those items don’t fit the specific needs of patients, we need to put on our thinking caps and start looking for other options for them. We’re sure that you compounders out there can come up with a few of your own as well.